Fear of COVID-19 and Physical Activity in Children With Asthma During the Covid Period

December 11, 2022 updated by: Şeyma Nur Önal, Bartın Unıversity

Fear of COVID-19 and Physical Activity Level of Children With Asthma

Social isolation rules applied to prevent and control COVID-19 disease reduce cross-infection, exposure to more allergens in the home environment, reducing hospital admissions by avoiding contamination, asthma control, fear of COVID-19 and physical activity for reasons such as increased anxiety and lack of exercise. How it will affect is unclear. Considering all these, positive or negative changes in asthma-related risk factors, changes in physical activity level, asthma attacks and control, fear of COVID-19 will be examined and contribute to the literature in children with asthma.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Social isolation rules applied to prevent and control COVID-19 disease reduce cross-infection, exposure to more allergens in the home environment, reducing hospital admissions by avoiding contamination, asthma control, fear of COVID-19 and physical activity for reasons such as increased anxiety and lack of exercise. How it will affect is unclear. Considering all these, positive or negative changes in asthma-related risk factors, changes in physical activity level, asthma attacks and control, fear of COVID-19 will be examined and contribute to the literature in children with asthma. Therefore, our primary aim in our study is; The aim of this study is to examine the asthma control and COVID-19 fear levels of asthmatic children who were in social isolation during the COVID-19 pandemic in children with asthma and compare their effects compared to healthy children. Our secondary aim in our study; The aim of this study is to examine the physical activity levels of children in social isolation during the COVID-19 pandemic in children with asthma.

Asthma Group Inclusion Criteria:

  • Having been diagnosed with asthma,
  • In addition, not having any chronic disease,
  • Volunteering to participate in the study,
  • Not having speech and hearing problems,
  • Being cooperative,
  • Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,

Asthma Group Exclusion Criteria:

  • The presence of a medical indication that requires complete restriction of physical activity,
  • To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
  • Having symptoms of COVID-19 and suspected illness,
  • Existence of cooperation and communication problems.

Healthy Group Inclusion Criteria

  • Not having any chronic disease for healthy individuals,
  • Volunteering to participate in the study,
  • Not having speech and hearing problems,
  • Being cooperative,
  • Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Healthy Group Exclusion Criteria

  • The presence of a medical indication that requires complete restriction of physical activity,
  • To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
  • Having symptoms of COVID-19 and suspected illness,
  • Existence of cooperation and communication problems

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bartın, Turkey
        • Bartın University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 14 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Asthmatic and healthy children and adolescents

Description

Inclusion Criteria:

  • Asthma Group Inclusion Criteria:
  • Having been diagnosed with asthma,
  • In addition, not having any chronic disease,
  • Volunteering to participate in the study,
  • Not having speech and hearing problems,
  • Being cooperative,
  • Not having mental, neurological, orthopedic, cardiovascular or pulmonary problems that would prevent physical activity,

Healthy Group Inclusion Criteria

  • Not having any chronic disease for healthy individuals,
  • Volunteering to participate in the study,
  • Not having speech and hearing problems,
  • Being cooperative,
  • Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Exclusion Criteria:

  • Asthma Group Exclusion Criteria:
  • The presence of a medical indication that requires complete restriction of physical activity,
  • To have had COVID-19 in the last 1 month or to be newly diagnosed with COVID-19,
  • Having symptoms of COVID-19 and suspected illness,
  • Existence of cooperation and communication problems. Healthy Group Inclusion Criteria
  • Not having any chronic disease for healthy individuals,
  • Volunteering to participate in the study,
  • Not having speech and hearing problems,
  • Being cooperative,
  • Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Asthma Group
Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.
Healthy Group
Parameters such as physical activity and fear of covid will be evaluated in asthmatic and healthy children and adolescents.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Questionnaire
Time Frame: 10 minutes
It will be evaluated by Physical Activity Questionnaire-Child and Physical Activity Questionnaire-Adolescent. The scale consists of 10 questions and item 10 questions the presence of an illness or an acute condition that limits physical activity. Frequent activities (hopping, walking, football, gymnastics, dance, etc.), level of participation in physical education class, and frequency of activities during break time, lunch time, after school, evening hours and weekends, during leisure time in the last seven days The frequency of the activities performed and the frequency of sports, dance, games and other similar physical activities seven days a week are questioned.
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asthma Control Test
Time Frame: 5 minutes
Asthma Control Test: The Asthma Control Test (AKT) was developed to evaluate people's asthma control. It consists of 5 questions. It is applied to children over 12 years old. Questions are scored between 1-5. A minimum of 5 points and a maximum of 25 points are taken. If the total score is 25, it is considered as complete control, 24-20 as partial control, and ≤19 as not under control (17). In the 2020 Asthma Guide update, the total score is defined as 5-15 uncontrolled asthma, 16-19 insufficient control, 20-25 good control. Uysal et al. The Cronbach's alpha value of the scale, whose validity and reliability in Turkish was made by Dr., was found to be 0.84 (18). It will be used in the form to be applied to adolescents.
5 minutes
Fear of COVID-19
Time Frame: 5 minutes

Qualitative Questions on Examining the Fear of COVID-19:

  1. I am very afraid of the coronavirus (Covid-19).
  2. I am afraid of dying from coronavirus.
  3. I can't sleep because of the fear of catching the coronavirus.

10. I am afraid of catching coronavirus and being hospitalized.

5 minutes
Social Isolation
Time Frame: 4 weeks

Social Isolation

  1. In the last 4 weeks, how many days have participants been out of the house outdoors? (park, nature, field, garden, etc.)
  2. In the last 4 weeks, how many days have participants been out of the house indoors? (shopping mall, workplace, market, home visit etc.)
  3. In the last 4 weeks, how many days has an outsider come to participants r home? (Guest, relative, etc.)
  4. In the last 4 weeks, how many days has someone from the house outside of participants went out of the house? (park, nature, field, garden, etc.)
  5. In the last 4 weeks, how many days has someone other than participants gone out of the house indoors? (shopping mall, workplace, market, home visit etc.)
  6. In the last 4 weeks, I have warned family members who have come from outside to wash their hands and faces before removing their masks.

Questions; Never, 1-3 days, 4-7 days, 7-15 days, 16-22 days, 23-30 days will be answered. The questions were created by the researchers.

4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şeyma Nur Önal, Bartın Unıversity

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2022

Primary Completion (Actual)

March 20, 2022

Study Completion (Actual)

December 12, 2022

Study Registration Dates

First Submitted

January 29, 2022

First Submitted That Met QC Criteria

January 31, 2022

First Posted (Actual)

February 2, 2022

Study Record Updates

Last Update Posted (Estimate)

December 13, 2022

Last Update Submitted That Met QC Criteria

December 11, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma in Children

Clinical Trials on Assessment

Subscribe